Canagliflozin

canagliflozin · Janssen Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

68 regulatory and trial events tracked for Canagliflozin, covering 2012-01-02 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Implementation of SGLT-2 Inhibitors in Patients With Heart Failure Through a New Digital Strategy [NA]